Stress, cortisol, and the hormonal terrain

Q: What about melatonin?

Melatonin is a prescription-only medicine in the UK; it is not available as a food supplement and we do not include it on this guide. Lower-dose over-the-counter products sold in other markets (most notably the United States) sit outside the UK licensed-medicines framework. If a reader is interested in melatonin specifically, that is a conversation with a GP, not a supplement decision.

Q: Can ashwagandha and rhodiola be used together?

The trial literature describes distinct use cases. Ashwagandha (Chandrasekhar 2012, KSM-66; Salve 2019) examines longer-term daily demands and cortisol over 60-day windows. Rhodiola (Darbinyan 2000, Spasov 2000, SHR-5) examines acute mental tiredness over shorter courses. The trials do not flag incompatibility. Pair only after considering the thyroid caveat below for ashwagandha.

Q: Are ashwagandha and rhodiola appropriate for everyone?

Ashwagandha has been reported in case studies and a placebo-controlled bipolar-disorder substudy to affect thyroid hormone readings in some individuals. Women with thyroid conditions, or on thyroid medication, should check with their GP before starting. General cautions apply for pregnancy and breastfeeding, and for anyone on prescribed sedatives or immunosuppressants. Rhodiola has a thinner safety record but is generally well-tolerated at the SHR-5 doses the research examines.

Q: What about L-theanine?

L-theanine has research examining a calm-focus profile, particularly paired with caffeine earlier in the day. It is not central to this guide — we focus on the higher-evidence ingredients above (Mg, ashwagandha, rhodiola, B-complex). L-theanine carries no UK authorised health claim.

Q: Why Solgar specifically? Are you the Solgar site?

We are not. HerStack is published by Suggestic, a digital nutrition company. We picked Solgar UK as the reference brand for three reasons set out in our formulation criteria: bioavailable forms across most of the range, transparent dosing on the labels, and third-party testing on the supplements we recommend. Where Solgar's formulation does not meet our criteria, we say so on the page and link to alternatives.

Q: How often is this article updated?

We review each cluster page against new evidence quarterly, and update the page header date when we make a substantive change. The recommendation rationale below carries its own last-reviewed date so you can see when the formulation reasoning was last checked.

Daily demands at midlife are not new — but the body's response to them shifts during perimenopause. Oestrogen has a moderating effect on cortisol; as oestrogen levels become more variable through the transition, that moderation weakens.[01] The result is a hormonal terrain on which the same demand registers differently than it did at 35. Caregiving load, career peak, rest patterns shifting, and metabolic shifts often compound.

The good news on the supplement side is that the four ingredient categories with the strongest editorial case — magnesium, ashwagandha, rhodiola, and a methylated B-complex — are well-mapped to the GB Nutrition & Health Claims register or to specific trial literature. Two carry GB-authorised wording for psychological function and tiredness/fatigue (magnesium and the relevant B vitamins).[02] Two are research-context ingredients — ashwagandha and rhodiola — where we describe the trial evidence without making benefit statements.

What the research examines

The strongest editorial case is built on Mg + B-complex authorised claims, with KSM-66 ashwagandha (Chandrasekhar 2012; Salve 2019) and SHR-5 rhodiola (Darbinyan 2000; Spasov 2000) as standardised-extract additions where the trial literature is specific enough to map a consumer formulation to a trial dose.[03]Most "wind-down" content leans on melatonin as a default; melatonin is prescription-only in the UK, so it is not part of this guide — see the FAQ for why.

Magnesium contributes to normal psychological function and to a reduction of tiredness and fatigue.

The retained EU 432/2012 register authorises both claims for magnesium. The glycinate form has the best digestive tolerance at the elemental doses the trial literature examines (typically 200–400 mg), which matters when a reader is taking it daily across a multi-month window. Magnesium glycinate is also the form we recommend on the perimenopause cluster — the nutrient case overlaps.

EU 432/2012 (retained GB)GB-authorised claim

Ashwagandha has trial evidence for cortisol and daily-stress measures — without a UK authorised health claim.

Chandrasekhar et al.'s 2012 placebo-controlled trial of a high-concentration KSM-66 extract (300 mg twice daily for 60 days, n=64) found significant reductions in serum cortisol and stress-rating-scale scores versus placebo. Salve et al.'s 2019 KSM-66 trial in healthy adults supports the daily-demands picture. Ashwagandha carries no UK authorised health claim, so we describe the trial work without making benefit statements.

Chandrasekhar 2012; Salve 2019RCT, n=64; RCT, n=60

Rhodiola appears in two SHR-5-extract trials examining mental tiredness under acute pressure.

Darbinyan et al.'s 2000 trial in night-duty physicians and Spasov et al.'s 2000 trial in students during examinations both used the standardised SHR-5 extract and reported measurable effects on mental-performance and fatigue measures over short courses. Both small (n<60) and now older; subsequent rhodiola trials exist but are mostly open-label. No UK authorised health claim — research-context only.

Phytomedicine · 2000Two RCTs, SHR-5 extract

B vitamins — particularly B5, methylfolate, and methylcobalamin — carry GB-authorised claims for psychological function and tiredness/fatigue.

The retained EU 432/2012 register authorises B6, B9 (folate), B12, and pantothenic acid (B5) for normal psychological function and the reduction of tiredness and fatigue. B6, B12, and folate also carry an authorised claim for the normal function of the nervous system. The cofactors above are sensitive to daily demands at midlife; a methylated, high-potency B-complex is a reasonable foundational addition.

EU 432/2012 (retained GB)GB-authorised claims, multiple B-vitamins

§ Evidence at a glance

What the research examines, side by side.

A scannable read of form, dose, and where the research sits — including the categories without UK authorised health claims, where we are explicit about the limit of what we can say.

Ingredient	Form examined	Reference dose	UK authorised wording
Magnesium[01] · EU 432/2012	Glycinate (bisglycinate)	200–400 mg/day elemental	Contributes to normal psychological function and to a reduction of tiredness and fatigue.
Ashwagandha[03][04] · KSM-66	Standardised root extract (KSM-66)	300 mg twice daily, 60 days	No UK authorised health claim — research-context only.
Rhodiola[05][06] · SHR-5	Standardised root extract (SHR-5)	Per published trial protocols	No UK authorised health claim — research-context only.
B-vitamins (B6, B9, B12, B5)[02] · EU 432/2012	Methylated forms preferred	Per label dose; methylfolate over folic acid	Contribute to normal psychological function, to a reduction of tiredness and fatigue, and (B6/B12/folate) to the normal function of the nervous system.

“Most ‘wind-down’ content leans on melatonin as a default. Melatonin is prescription-only in the UK, so it is not part of this guide. The research-supported, UK-available ingredients are different — and mostly better-tolerated.”— HerStack editorial standards, § 3.4

§ Reader questions

Six things readers keep asking.

Pulled from the most-read questions on the stress cluster. Each answer reflects what the research currently supports and what UK compliance allows us to say.

What about melatonin?

Melatonin is a prescription-only medicine in the UK; it is not available as a food supplement and we do not include it on this guide. Lower-dose over-the-counter products sold in other markets (most notably the United States) sit outside the UK licensed-medicines framework. If a reader is interested in melatonin specifically, that is a conversation with a GP, not a supplement decision.

Can ashwagandha and rhodiola be used together?

The trial literature describes distinct use cases. Ashwagandha (Chandrasekhar 2012, KSM-66; Salve 2019) examines longer-term daily demands and cortisol over 60-day windows. Rhodiola (Darbinyan 2000, Spasov 2000, SHR-5) examines acute mental tiredness over shorter courses. The trials do not flag incompatibility. Pair only after considering the thyroid caveat below for ashwagandha.

Are ashwagandha and rhodiola appropriate for everyone?

Ashwagandha has been reported in case studies and a placebo-controlled bipolar-disorder substudy to affect thyroid hormone readings in some individuals. Women with thyroid conditions, or on thyroid medication, should check with their GP before starting. General cautions apply for pregnancy and breastfeeding, and for anyone on prescribed sedatives or immunosuppressants. Rhodiola has a thinner safety record but is generally well-tolerated at the SHR-5 doses the research examines.

What about L-theanine?

L-theanine has research examining a calm-focus profile, particularly paired with caffeine earlier in the day. It is not central to this guide — we focus on the higher-evidence ingredients above (Mg, ashwagandha, rhodiola, B-complex). L-theanine carries no UK authorised health claim.

Why Solgar specifically? Are you the Solgar site?

We are not. HerStack is published by Suggestic, a digital nutrition company. We picked Solgar UK as the reference brand for three reasons set out in our formulation criteria: bioavailable forms across most of the range, transparent dosing on the labels, and third-party testing on the supplements we recommend. Where Solgar's formulation does not meet our criteria, we say so on the page and link to alternatives.

How often is this article updated?

We review each cluster page against new evidence quarterly, and update the page header date when we make a substantive change. The recommendation rationale below carries its own last-reviewed date so you can see when the formulation reasoning was last checked.

§ What we recommend

Three reference picks, with formulation reasoning.

Each card carries the form we'd choose, the rationale in 2–3 sentences, the authorised-claim text where one applies, and a link to Amazon.co.uk. A methylated B-complex is the obvious fourth — we already recommend it on the perimenopause cluster, and the nutrient case is identical here. Affiliate disclosure sits in the footer of every page.

Magnesium · Glycinate

Solgar Magnesium Glycinate Capsules

The same SKU we recommend on the perimenopause cluster — the nutrient case overlaps. Glycinate is the form with the best digestive tolerance at the elemental doses the trial literature examines (200–400 mg). A defensible foundational supplement for women in the transition who are noticing daily-demands shifts; the dose can be tiered across the day or weighted toward the evening.

Magnesium contributes to normal psychological function and to a reduction of tiredness and fatigue.

£15.99Reference pick

View on Amazon.co.uk →

Ashwagandha · Standardised root extract

Solgar Ashwagandha Root Extract Vegetable Capsules

Standardised root extract; Solgar's UK formulation lists the standardised withanolide content on the label, which is what lets you map a consumer SKU to the trial-literature dose range (Chandrasekhar 2012 used 300 mg KSM-66 twice daily). Ashwagandha carries no UK authorised health claim, so we describe the formulation and the trial work without making benefit statements. Read the thyroid FAQ above before starting.

Ashwagandha carries no UK authorised health claim. We name the standardisation and the trial citations; we do not make a benefit statement.

£26.16Reference pick

View on Amazon.co.uk →

Rhodiola · Standardised SHR-5 complex

Solgar Balance Rhodiola Complex Vegetable Capsules

A complex built around a standardised rhodiola root extract. The Darbinyan 2000 night-shift-physician trial and the Spasov 2000 examinations trial both used the SHR-5 extract; trial doses were modest by adaptogen standards. Solgar's standardisation lets you map the consumer dose to those references. No UK authorised health claim — we describe the trial picture without asserting a benefit.

Rhodiola carries no UK authorised health claim. We name the formulation and the trial citations; we do not make a benefit statement.

£22.50Reference pick

View on Amazon.co.uk →

§ What to look for in a brand

Two criteria specific to standardised botanicals.

Beyond the universal three — bioavailable form, transparent dose, third-party testing — the standardised-botanical category rewards a couple of additional checks.

Criterion · 01

Standardisation declared on the label

“Ashwagandha root 500 mg” is not the same as “Ashwagandha root extract standardised to 5% withanolides, 300 mg.” The latter is what most of the trial evidence examines. Brands that publish standardisation are the ones whose dose you can map to the research; brands that don't are asking you to trust generic root powder against trial-extract outcomes.

Criterion · 02

Specific extract identifiers

KSM-66 and Sensoril are specific patented ashwagandha extracts with their own trial bases. SHR-5 is the rhodiola extract used in Darbinyan 2000 and Spasov 2000. Generic root powder does not necessarily carry the same outcomes. Solgar's botanical range generally meets the standardisation criterion; readers can confirm the named extract on the current Solgar UK label before purchasing.

Criterion · 03

Methylated B-vitamin forms

For B-complex specifically, the methylated forms (methylfolate over folic acid; methylcobalamin over cyanocobalamin) are what most of the recent literature examines and what readers carrying common methylation polymorphisms can use directly. A high-potency B-complex that ships methylfolate and methylcobalamin is the appropriate default.

§ Citations

Sources, in the order they appear.

[01] GB Nutrition & Health Claims register / Commission Regulation (EU) No 432/2012 (retained). Magnesium — contribution to normal psychological function and to a reduction of tiredness and fatigue. gov.uk/health-claims
[02] GB Nutrition & Health Claims register / Commission Regulation (EU) No 432/2012 (retained). B-vitamin authorised claims — B6, B9 (folate), B12 and B5 (pantothenic acid) for normal psychological function and the reduction of tiredness and fatigue; B6/B12/folate for normal function of the nervous system. gov.uk/health-claims
[03] Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med, 2012;34(3):255-62. (KSM-66 300 mg BID, n=64.) PMID 23439798
[04] Salve J, Pate S, Debnath K, Langade D. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus, 2019;11(12):e6466. (KSM-66, n=60.) DOI 10.7759/cureus.6466
[05] Darbinyan V, Kteyan A, Panossian A et al. Rhodiola rosea in stress-induced fatigue — a double-blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine, 2000;7(5):365-71. PMID 11081987
[06] Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine, 2000;7(2):85-9. PMID 10839209
[07] Gannon JM, Forrest PE, Roy Chengappa KN. Subtle changes in thyroid indices during a placebo-controlled study of an extract of Withania somnifera in persons with bipolar disorder. Journal of Ayurveda and Integrative Medicine, 2014;5(4):241-5. PMC 4296437
[08] NIH Office of Dietary Supplements. Magnesium — Health Professional Fact Sheet. ods.od.nih.gov/factsheets/Magnesium-HealthProfessional
[09] NIH Office of Dietary Supplements. Vitamin B6, Folate, and Vitamin B12 — Health Professional Fact Sheets. ods.od.nih.gov/factsheets/list-all
[10] Medicines and Healthcare products Regulatory Agency (MHRA). Melatonin — UK licensed-medicines status; not available as a food supplement. gov.uk/MHRA